No Data
No Data
Deutsche Numis Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $103
Deutsche Numis analyst Pito Chickering maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and maintains the target price at $103.According to TipRanks data, the analyst has a success rate of 5
Deutsche Numis Sticks to Their Buy Rating for Edwards Lifesciences (EW)
Edwards Lifesciences Corporation (NYSE:EW) Is Favoured by Institutional Owners Who Hold 84% of the Company
Is Edwards Lifesciences Corp (NYSE:EW) the Best Medical Stock to Buy in 2024?
J.P. Morgan Maintains Edwards Lifesciences(EW.US) With Buy Rating
J.P. Morgan analyst Robbie Marcus maintains $Edwards Lifesciences(EW.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 54.6% and a total average return of 11.6% over
CNBC Halftime Report Final Trades: Edwards Lifesciences, American Tower, Transdigm
CNBC Halftime Report Final Trades: Edwards Lifesciences, American Tower, Transdigm